SK Biopharmaceuticals to Initiate Phase 2 Trials in US

SEOUL, South Korea--(BUSINESS WIRE)--SK Biopharmaceuticals has initiated a Phase 2 study for SKL11197 in the US in patients with diabetic peripheral neuropathic pain.

Feed Date: 
February 21, 2012